Results 81 to 90 of about 8,287 (164)

Anesthesia and Outcome of 33 Surgeries in 24 Multiple Endocrine Neoplasia Type 2A (MEN2A) Patients: A National Rare Disease Center's Experience. [PDF]

Front Endocrinol (Lausanne), 2022
Li Y, Jin D, Shen L, Huang Y.
europepmc   +1 more source

Efficacy of iodine-131-metaiodobenzylguanidine therapy for multiple endocrine neoplasia type 2A-associated metastatic pheochromocytoma: case report and literature review

Endocrine Journal
Malignant transformation in multiple endocrine neoplasia type 2 (MEN2)-associated pheochromocytoma is rare, and there have been few reports of treatment with 131I-metaiodobenzylguanidine (MIBG) therapy.
Kentaro Suda, Noriko Kimura, Toshihiro Maeda, Shiro Watanabe, Sachiyo Nishida, Hiroaki Shima, Taro Sugawara, Shinya Uchino, Aki Ishikawa, Toshiaki Tanaka, Masato Furuhashi, Naoya Masumori, Akihiro Sakurai   +12 more
doaj   +1 more source

Laparoscopic resection of aortocaval paraganglioma diagnosed by serial increase in urinary metanephrines after bilateral adrenalectomy in a patient with multiple endocrine neoplasia type 2A. [PDF]

IJU Case Rep, 2021
Miyata Y, Hatano K, Okuno Y, Ujike T, Fukuhara S, Uemura M, Kiuchi H, Imamura R, Otsuki M, Nonomura N.   +9 more
europepmc   +1 more source

Multiple endocrine neoplasia type 2A. Study of a family.

Revista portuguesa de cardiologia : orgao oficial da Sociedade Portuguesa de Cardiologia = Portuguese journal of cardiology : an official journal of the Portuguese Society of Cardiology, 2000
Pheochromocytomas (Pheo) can occur sporadically, isolated or in association with other neuroendocrine lesions. In multiple endocrine neoplasia type 2A (MEN-2A), Pheo is associated to medullary thyroid carcinoma (MTC) or its precursor, C-cell hyperplasia (CCH) and parathyroid hyperplasia.
M J, Correia, L O, Lopes, M J, Bugalho, L, Cristina, A I, Santos, A D, Bordalo, B, Pinho, H L, da Silva, M D, Gonçalves, C, Ribeiro, J L, Tuna   +10 more
openaire   +1 more source

Multiple endocrine neoplasia type 2A: case report.

Chirurgia (Bucharest, Romania : 1990), 2014
Multiple endocrine neoplasia type 2A (MEN 2A) is a complex autosomal dominant inherited syndrome characterized by medullary thyroid carcinoma (MTC), pheochromocytoma and primary parathyroid hyperplasia. In patients with only one or two clinical features, identification of a germline RET(REarranged in Transfection) mutation or the identification of the ...
D L, Păun, C, Poiană, R, Petriş, S, Radian, R Dănciulescu, Miulescu, G, Constantinescu, C, Orban   +6 more
openaire   +1 more source

Sporadic Multiple Endocrine Neoplasia Type 2A

Internal Medicine, 1999
openaire   +3 more sources

Advanced disease and biochemical phenotype shift in multiple endocrine neoplasia type 2A-related pheochromocytoma. [PDF]

JCEM Case Rep
Yanagida J, Horiuchi K, Yoshida Y, Yamamoto T.   +3 more
europepmc   +1 more source

The synergy of germline C634Y and V292M RET mutations in a northern Chinese family with multiple endocrine neoplasia type 2A. [PDF]

J Cell Mol Med, 2020
Yang Z, Qi X, Gross N, Kou X, Bai Y, Feng Y, Wang B, Zafereo ME, Li G, Sun C, Li H, Chen X, Huang Z.   +12 more
europepmc   +1 more source

Sarcoidosis-Induced Hypercalcemia in a Patient With Multiple Endocrine Neoplasia Type 2A (MEN2A) Syndrome Harboring the C609Y REarranged During Transfection (RET) Mutation. [PDF]

AACE Endocrinol Diabetes
Ibrahim E, Cheema Z, Walaliyadda P, Ali Hashim MM, Elbanan M, Khan U.   +5 more
europepmc   +1 more source

Long-term Clinicopathological Features of a Family with Multiple Endocrine Neoplasia Type 2A Caused by C634R RET Gene Mutation. [PDF]

Indian J Nucl Med, 2020
Prabhu M, Shakya S, Ballal S, Shamim SA, Bal C.   +4 more
europepmc   +1 more source